152 related articles for article (PubMed ID: 38722138)
1. miRNA-143 as a potential biomarker in the detection of bladder cancer: a meta-analysis.
Li J; Li H; Yang Y; Sen Y; Ye J
Future Oncol; 2024 May; ():1-13. PubMed ID: 38722138
[TBL] [Abstract][Full Text] [Related]
2. Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis.
Cheng Y; Deng X; Yang X; Li P; Zhang X; Li P; Tao J; Lu Q; Wang Z
Onco Targets Ther; 2015; 8():2089-96. PubMed ID: 26316777
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
Chen L; Cui Z; Liu Y; Bai Y; Lan F
Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of urine and blood microRNAs for bladder cancer: a meta-analysis.
Ye Q; Wang J; Xu D; Liu Y; Zhang D; Ye J; Li H
Expert Rev Anticancer Ther; 2022 Dec; 22(12):1357-1369. PubMed ID: 36374119
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
Dong F; Shen Y; Xu T; Wang X; Gao F; Zhong S; Chen S; Shen Z
World J Surg Oncol; 2018 Mar; 16(1):61. PubMed ID: 29562940
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of UCA1 accuracy in the detection of bladder cancer.
He S; Xu J; Chen M; Li J; Li S; Ye J
Expert Rev Anticancer Ther; 2024 Jun; 24(6):447-455. PubMed ID: 38606888
[TBL] [Abstract][Full Text] [Related]
7. Urine miRNA as a potential biomarker for bladder cancer detection - a meta-analysis.
Kutwin P; Konecki T; Borkowska EM; Traczyk-Borszyńska M; Jabłonowski Z
Cent European J Urol; 2018; 71(2):177-185. PubMed ID: 30038807
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA panels as diagnostic biomarkers for colorectal cancer: A systematic review and meta-analysis.
Sur D; Advani S; Braithwaite D
Front Med (Lausanne); 2022; 9():915226. PubMed ID: 36419785
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of urinary microRNAs as non-invasive biomarkers for bladder cancer: a meta-analysis.
Ding M; Li Y; Wang H; Lv Y; Liang J; Wang J; Li C
Int J Clin Exp Med; 2015; 8(9):15432-40. PubMed ID: 26629032
[TBL] [Abstract][Full Text] [Related]
10. A four-miRNA signature in serum as a biomarker for bladder cancer diagnosis.
Li R; Chen X; Li X; Huang G; Lu C; Wen Z; Chen Z; Lai Y
Am J Transl Res; 2022; 14(7):4606-4616. PubMed ID: 35958461
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as noninvasive biomarkers in bladder cancer detection: a diagnostic meta-analysis based on qRT-PCR data.
Xiao S; Wang J; Xiao N
Int J Biol Markers; 2016 Jul; 31(3):e276-85. PubMed ID: 26954073
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of Raman spectroscopy for the diagnosis of bladder cancer: A systematic review and meta-analysis.
Kim DK; Kim YH; Lee HY; Lee S; Doo SW; Yang WJ; Song YS; Kim KH; Kim JH
J Cancer Res Ther; 2021; 17(2):426-433. PubMed ID: 34121688
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Salivary miRNA in Head and Neck Squamous Cell Cancer: Systematic Review and Meta-Analysis.
Kang JW; Eun YG; Lee YC
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209954
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.
Cui Z; Lin D; Song W; Chen M; Li D
Tumour Biol; 2015 Feb; 36(2):829-39. PubMed ID: 25296735
[TBL] [Abstract][Full Text] [Related]
15. Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis.
Aalami AH; Abdeahad H; Mesgari M; Sathyapalan T; Sahebkar A
Biomed Res Int; 2021; 2021():5557309. PubMed ID: 33997007
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of miRNAs for the detection of cervical cancer.
Hillyar CR; Kanabar SS; Pufal KR; Saw Hee JL; Lawson AW; Mohamed Y; Jasim D; Reed L; Rallis KS; Nibber A
Epigenomics; 2023 May; 15(10):593-613. PubMed ID: 37535320
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of circulating miRNAs to discriminate hepatocellular carcinoma from liver cirrhosis: a systematic review and meta-analysis.
Alemayehu E; Belete MA; Walle M; Getu F; Mulatie Z; Teshome M; Anley DT; Weldehanna DG; Gedefie A; Ebrahim H
Front Med (Lausanne); 2024; 11():1359414. PubMed ID: 38721351
[TBL] [Abstract][Full Text] [Related]
18. Urinary miRNAs as a Diagnostic Tool for Bladder Cancer: A Systematic Review.
Grimaldi AM; Lapucci C; Salvatore M; Incoronato M; Ferrari M
Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359288
[TBL] [Abstract][Full Text] [Related]
19. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
[TBL] [Abstract][Full Text] [Related]
20. Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.
Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Jiang Y
World J Urol; 2020 Jan; 38(1):129-142. PubMed ID: 30919100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
